| abstract |
The invention relates to a thymosin alpha 1 active fragment cyclopeptide derivative with natural or non-natural amino acid replacement, a preparation method thereof, a drug combination containing the thymosin alpha 1 active fragment cyclopeptide derivative, and a drug of the thymosin alpha 1 active fragment cyclopeptide derivative for treating or preventing related diseases such as immunodeficiency and impaired immunity. |